AzTrials
AzTrials

StrokeNCT07698522

Digital Technology-Informed Stroke Rehabilitation

A study testing Lab-based movement guidance and Home-based movement guidance in people with Stroke, run by University of Utah at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to determine the effects of lab and home-based technology guidance during movement training post-stroke. The study will compare movement training informed by lab-based technology to training delivered with technology at home. Read more about this study

Who is it for?
Ages 30 to 85 years
Conditions the study is for
Stroke
What is being tested?
Lab-based movement guidance and Home-based movement guidance
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
27 Jul 2026to Dec 2033
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 30-85 years.
  • Diagnosis of stroke.
  • Stroke onset of at least six months prior to the time of participation.
  • Fugl Meyer Upper Extremity between 30-50 (mild-moderate)
  • Cognitive skills to consent and actively participate, as indicated by scores of ≥ 24 on the Mini- Mental Status Examination
  • Able to visit lab up to 5x per week for 3 weeks

Who cannot join

  • Presence of severe aphasia preventing the ability to follow 1-step directions at least 80% of the time.
  • Excessive spasticity of the wrist, elbow, and shoulder, defined as a Modified Ashworth Score >2.
  • Diagnosis of neurological disorders other than stroke.
  • Orthopedic/musculoskeletal conditions (e.g., severe arthritis) affecting the upper extremity.
  • Currently or planning to become pregnant.
  • Participation in concurrent occupational therapy.
  • Unilateral neglect, defined as failure of the Line Bisection Task
  • Upper extremity pain >= 7/10 on Numeric Rating Scale

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • Kennecott Mechanical Engineering Building

    Salt Lake City, Utah, 84112

    Scott Uhlrich, PhD

    Recruiting

Other trials in United States

About this study

The goal of this study is to determine the effects of lab and home-based technology guidance during movement training post-stroke. The study will compare movement training informed by lab-based technology to training delivered with technology at home. The main questions it aims to answer are:

  • How well do lab and home-based technologies help individuals post-stroke improve their movement patterns?
  • Is there a difference in improvement between the in-lab and at-home training groups?
  • Which technologies lead to the most improvement?
Read the detailed description

The study is a randomized, controlled feasibility trial investigating rehabilitation to improve movement patterns after stroke. The study will recruit participants who have had a stroke that led to upper-extremity impairment. Individuals will be assigned to one of two digital technology-guided groups. One group will be guided through exercises in a home-based setting, the other will be lab-based.

Participants will engage in training sessions multiple days a week for up to 6 weeks, either in-lab or at home. Both groups will visit the lab weekly for movement assessments.

Conditions
Stroke
Being tested
Lab-based movement guidance, Home-based movement guidance
Keywords
movement training, rehabilitation, occupational therapy
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lab-based movement guidanceOther

    Participants will receive computer-generated guidance on how to perform different activities of daily living efficiently. The guidance will be delivered using lab-based sensing and feedback technology.

  • Home-based movement guidanceOther

    Participants will receive computer-generated guidance on how to perform different activities of daily living efficiently. This guidance will be delivered using home-based technologies, such as a computer or tablet.

Study groups in NCT07698522
Study groupRoleWhat they receive
At-Home TrainingExperimentalParticipants will train at-home.
Receives: Other: Home-based movement guidance
In-Lab TrainingExperimentalParticipants will train in the lab.
Receives: Other: Lab-based movement guidance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Kinematic movement quality score

    A score based on subject kinematics during a daily task (like reaching), comparing the subject's reaching kinematics to normative kinematics.

    Measured: From enrollment to the end of treatment at 3 weeks.

Secondary outcomes (1)
  1. FMA-UE Score

    Upper Extremity Fugl-Meyer Score

    Measured: From enrollment to the end of treatment at 3 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2026
  2. Study start27 Jul 2026
  3. Primary completionDec 2033 (estimated)
  4. Study completionDec 2033 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07698522
Sponsor's protocol ID
IRB_00203244
Status last verified
Jul 2026
First submitted
6 Jul 2026
Last updated
24 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We will share participant demographics and outcomes data. We will also share kinematics data. These data will be shared on SimTK.org.

Questions about this trial

What is this clinical trial studying?

A study testing Lab-based movement guidance and Home-based movement guidance in people with Stroke, run by University of Utah at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Samantha McNeill ((385) 215-9146‬, samantha.mcneill@utah.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Kinematic movement quality score (time frame: From enrollment to the end of treatment at 3 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Digital Technology-Informed Stroke Rehabilitation | AzTrials